Reprogramming the Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer via FAP‐Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy
Advanced Materials · 2026-08 · 38 (47)
DOI: 10.1002/adma.74089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 15.07.2026. Verfasst von Ling Zhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Microenvironment, Gelatinases, Photothermal Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Explorer Program of the Science and Technology Commission of Shanghai Municipality, Shanghai Oriental Talent Plan Leading Project.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) poses a major clinical challenge because of its aggressive behavior, high likelihood of metastasis, and absence of specific therapeutic targets. The immunosuppressive tumor microenvironment, largely influenced by cancer‐associated fibroblasts (CAFs) through fibroblast activation protein (FAP)‐mediated extracellular matrix (ECM) remodeling and cytokine secretion, contributes to TNBC's resistance to immunotherapy. In response to this challenge, we have developed FAP‐targeted nanoprobes (FAP‐IR1061) that incorporate second near‐infrared (NIR‐II) fluorescence/magnetic resonance (MR)/photoacoustic (PA) imaging capabilities alongside highly efficient NIR‐II photothermal conversion for precision theranostics. This platform facilitates a tripartite therapeutic approach: (1) selective ablation of CAFs and dismantling of the ECM to overcome physical barriers; (2) spatiotemporal induction of immunogenic cell death through the release of damage‐associated molecular patterns; (3) functional repolarization of tumor‐associated neutrophils toward antitumor N1 phenotypes. When used in conjunction with anti‐programmed cell death protein 1 (αPD‐1) therapy, this strategy achieves over 80% suppression of both primary and distant tumors by enhancing the infiltration of cytotoxic T lymphocytes. Collectively, these effects promote the establishment of long‐term antitumor immune memory, which facilitates tumor eradication and prevents tumor recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Faculty of Medical Imaging Technology, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Defan Yao, Dengbin Wang
Förderung
- National Natural Science Foundation of China
- Explorer Program of the Science and Technology Commission of Shanghai Municipality
- Shanghai Oriental Talent Plan Leading Project
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Zhan, L., Chen, Y., Hu, J., Wang, C., Liu, H., Yao, D., & Wang, D. (2026). Reprogramming the Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer via FAP‐Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy. Advanced Materials, 38(47). https://doi.org/10.1002/adma.74089
Vancouver
Zhan L, Chen Y, Hu J, Wang C, Liu H, Yao D, et al. Reprogramming the Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer via FAP‐Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy. Advanced Materials. 2026;38(47). doi:10.1002/adma.74089
BibTeX
@article{Zhan2026,
author = {Zhan, Ling and Chen, Yanhong and Hu, Jingjing and Wang, Chunting and Liu, Huanhuan and Yao, Defan and Wang, Dengbin},
title = {Reprogramming the Immunosuppressive Microenvironment in Triple‐Negative Breast Cancer via FAP‐Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {47},
doi = {10.1002/adma.74089}
}
EUVIMED